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impact of child gastroenteritis on parents. METHODS: A litera-
ture review was conducted to create the ﬁrst conceptual model.
Semi-directive interviews of 10 parents were conducted and
analysed to create items. A 54-item self-administered question-
naire was simultaneously developed in French and UK English
and cognitive debrieﬁngs were conducted with 5 parents. The
questionnaire was linguistically validated in Spanish, Italian and
Polish and included in an observational and prospective study
conducted with 302 parents of children under 5 presenting at the
general practitioner/paediatrician site with acute gastroenteritis.
Multitrait analysis and item content were used to conﬁrm the
dimensions and deﬁne the scoring of the questionnaire. Internal
consistency reliability (Cronbach’s alpha), ﬂoor and ceiling
effects, scale-scale correlations and criterion validity of the result-
ing version were assessed. RESULTS: The ﬁnal version of the
questionnaire consists of 44 items in ﬁve dimensions: “Symptom
Severity” (13 items), “Parents’ Worries due to Symptoms” (8
items), “Child’s Behaviour” (6 items), “Impact on Parents’ Daily
Activities” (10 items) and “Parents’ Distress” (7 items). Higher
scores indicate higher levels of negative feelings. All the scores
presented good psychometric properties: no dimension had a
ﬂoor or ceiling effect, Cronbach’s alpha ranged from 0.78 to 0.85
showing a good internal consistency reliability, and scale-scale
correlations ranged from 0.41 to 0.67 showing consistency but
no redundancy between the dimensions. Correlations with
Clark’s and Vesikari’s scores showed a good criterion validity.
The more severe the gastroenteritis episode, the higher the scores
of the questionnaire. CONCLUSIONS: The “Impact of child
gastroenteritis on parents” questionnaire allows a very complete
overview of how an episode of severe gastroenteritis impacts the
parents of the ill child. The questionnaire is a valid and reliable
instrument, suitable for future studies.
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OBJECTIVES: To compare the ability of individual and societal
preference scores based on the EQ-5D to identify active inﬂam-
matory bowel disease (IBD) in Germany. METHODS: Members
of the German IBD Association documented Health-Related
Quality of Life (hrQoL) with the EQ5-D and other disease-
related factors. Inactive or active disease was based on calculated
IBD activity indices. Disease activity was also classiﬁed (present
or absent) according to sick-leave and hospitalizations, docu-
mented retrospectively (three months) and prospectively (four
weeks). EQ-5D index scores were calculated using British (EQ-
5DBT) and German (EQ-5DGT) tariffs. Differences in EQ VAS
and EQ-5D index scores between patient groups differing in
disease activity, sick-leave and hospitalizations were determined
by effect size (ES) and bootstrap test for the standardised differ-
ence between the means. ES and bootstrap-test probability are
always reported in this consecutive order: EQ VAS, EQ-5DBT
and EQ-5DGT. RESULTS: A total of 527 retrospective and 483
prospective questionnaires were analysed. Retrospectively, 20%
reported sick-leave, 7% hospitalisation, whereas prospectively,
12% reported sick-leave, 2% hospitalisation. 39% had active
disease. All preference scores differed signiﬁcantly between
patients with active and inactive disease (ES: 13.72, 11.47, 9.56;
p: 0.0001(all)). Retrospectively, ES of preference scores of
patients differing in sick-leave (ES: 4.35, 4.51, 3.37; p: 0.0001,
0.0001, 0.002) and hospitalisation (ES: 2.07, 2.17, 1.91; p:
0.047, 0.047, 0.081) were large. Prospectively, the ES of prefer-
ence scores for sick-leave groups (ES: 4.34, 4.32, 3.00; p: 0.0001,
0.0002, 0.0119) and hospitalisation (ES: 3.45, 3.08, 2.50;
p: 0.014, 0.022, 0.061) were also large. CONCLUSIONS: In
German IBD subjects, the ES of all preference scores was large
regarding disease-activity, sick-leave and hospitalisation both ret-
rospectively and prospectively. Bootstrap-test probability showed
that the EQ-5DGT discriminated less well between the groups
than the other preference scores.
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OBJECTIVES: Limited epidemiological data are available con-
cerning gastroesophageal reﬂux disease (GERD). The aims of
this study were to estimate the proportion of patients with
GERD-related symptoms in primary care, and to describe the
symptom burden and clinical management of the disease.
METHODS: RANGE-Greece was part of a European pro-
gramme, which was conducted in six countries and comprised
similar cross-sectional studies run in parallel. RANGE-Greece
recruited retrospectively identiﬁed patients who visited an ofﬁce-
based gastroenterologist for a GERD-related reason during a
4-month period (index visit). Consenting subjects were invited to
attend a study visit. Data collection was performed for both the
index and study visits. Patient-reported outcomes were collected
by means of validated questionnaires (RDQ, XQS, GIS, WPAI-
GERD). RESULTS: From the 29,903 patients identiﬁed by 23
gastroenterologists, 2116 (7.1%) had GERD-related reasons for
the index visit. 505 randomly selected patients, who consented
to participation, comprised the analysed population. Mean
(SD) age was 52 (14) years; 52.5% were women. The main
reasons for the index visit were: recurrent symptoms after a
remission period (41.8%), new reﬂux symptoms in a treatment-
naïve patient (35.6%), persistence of previous reﬂux symptoms
(10.9%), and follow-up visit in an asymptomatic patient (5.5%).
57.4% of patients had an endoscopic diagnosis. At the index
visit, 99.8% of patients were prescribed a proton pump inhibi-
tor. The study visit was performed after a median of 6.5 months.
A total of 40.6% of patients had not changed treatment,
whereas 23.6% and 21.0% were still suffering from heartburn
and acid regurgitation, respectively (frequency 2 days the pre-
vious week). Symptom severity was moderate in 29.3% and
22.8% and severe in 3.2% and 4.2% of patients with heartburn
and acid regurgitation, respectively. CONCLUSIONS: Despite
medical attention and treatment a considerable proportion of
patients did not achieve an acceptable control of GERD-related
symptoms.
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OBJECTIVES: GERD is associated with obesity, age and gender
in several studies. The GERD impact scale is a validated one-page
self-administered questionnaire that asks patients about GERD
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